genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
GEN Edge
Assessing Coronavirus Impact on Wall Street
GEN Edge
At Laboratory for Advanced Medicine, New CEO Sharpens Commercial Focus
GEN Edge
Regeneron Hits the Accelerator
GEN Edge
Global Blood Therapeutics CEO Defends Price of Sickle-Cell Drug Oxbryta
GEN Edge
Trial Triumphs, Takeover Talk Boost Reata Pharmaceuticals
News
Coronavirus
Harvard, Guangzhou Institute Launch $115M Coronavirus Research Collaboration
News
Male Autism Brains Deficient in Key Inflammatory Protein
Aging
Existing Theory Explaining the Effects of Restricted Diet on Lifespan Challenged
News
Multiple Mechanisms Found that Prevent Effective Immune Checkpoint Inhibitor Therapy
News
Aromatherapy Wafts toward Drug Discovery Space
Insights
All
Trends for 2020
Insights
The Vertex Method’s Success Story
Commentary
Translating Pharmacomicrobiomics: Three Actionable Challenges/Prospects in 2020
Insights
Optogenetic Modulation for the Treatment of Traumatic Brain Injury
Coronavirus
What We Know Today about Coronavirus SARS-CoV-2 and Where Do We…
A-Lists
Insights
Top 10 Life Sciences Jobs Most in Demand over the Next…
GEN Edge
Ten Life Science Analysts to Watch in 2020
Insights
Top 10 Young Companies in the Money, 2019
January 2020 Vol. 40 No. 1
8 Biopharma Trends to Watch in 2020
Cancer
Top 10 Immuno-Oncology Startups of 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Insights
The Vertex Method’s Success Story
Coronavirus
Harvard, Guangzhou Institute Launch $115M Coronavirus Research Collaboration
Commentary
Translating Pharmacomicrobiomics: Three Actionable Challenges/Prospects in 2020
Aging
Existing Theory Explaining the Effects of Restricted Diet on Lifespan Challenged
Magazine
February 2020 Vol. 40 No. 2
Building SynBio Platforms to Support Practical Apps
February 2020 Vol. 40 No. 2
Phage Therapy May Combine Efficacy and Convenience
February 2020 Vol. 40 No. 2
Guilty as Charged
February 2020 Vol. 40 No. 2
Gene Therapy Dollar Is Waiting on Viral Vector Dime
February 2020 Vol. 40 No. 2
Antibody Screening Technology Is Never Out of Sorts
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
The Successful Evolution of Biotherapies from Discovery to Development
February 2020 Vol. 40 No. 2
A Small-Footprint, Integrated, and Automated Platform for Viral Production
Drug Discovery
Assessing Phenotypic Changes in Zebrafish through Automated Quantitative Imaging
10x Genomics
Bridging Genomics and Tissue Pathology
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Cancer
Ovarian Cancer
Ovarian Cancer
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Ovarian Cancer
Ovarian Cancer Drug Resistance Protein Identified
Ovarian Cancer
ImmunoGen Axing Nearly 75% of Workforce, Shrinking Pipeline and Facilities
Ovarian Cancer
Novel Ovarian Cancer Diagnostic May Eliminate Need for Exploratory Surgery
Ovarian Cancer
Cancer Liquid Biopsy Developer Thrive Launches with $110M in Series A Financing
Ovarian Cancer
Liquid Biopsies Can Point to Best Ovarian Cancer Treatment
Ovarian Cancer
ImmunoGen Shares Plunge after Phase III Failure of Lead ADC in...
Ovarian Cancer
Artificial Intelligence Improves Ovarian Cancer Prognosis
Ovarian Cancer
GSK to Acquire PARP Inhibitor Developer Tesaro for $5.1B
Ovarian Cancer
Anti-Cancer Drug Effects Measured at Single-Cell Level by Multidimensional Technique
Ovarian Cancer
Personalized Cancer Vaccine Shows Promise in Patients with Advanced Ovarian Cancer
Ovarian Cancer
Newly Uncovered Pathway Points to New Strategies Against Ovarian Cancer
Ovarian Cancer
Immunotherapy Raises the Stakes and Ovarian Cancer Blinks
Ovarian Cancer
BRCA1/2 Testing Protocols Vary Extensively Worldwide
Ovarian Cancer
Chemo Fails Reversed by Blocking Cancer Cells’ Toxin Pumps
Ovarian Cancer
Stanford Spinout Partners with Merck KGaA, Genentech in Cancer Studies of...
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Multidimensional analysis of PARP toxicity using automated high-content microscopy. Various key parameters of cellular responses are investigated. [University of Zurich]](https://www.genengnews.com/wp-content/uploads/2018/08/Jul11_2018_UnivZurich_EffectsOfDrugsOnCancerCells2521233144-324x160.jpg "Anti-Cancer Drug Effects Measured at Single-Cell Level by Multidimensional Technique")
